Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Acquisition of Solar Panel Recycling Technology June 18, 2025 Coinbase Backs QCAD Stablecoin to Power Canadian Crypto... May 17, 2025 Agreement to Develop New Expandable Graphite Facility July 28, 2025 Crypto Market Update: SEC Pauses Bitwise ETF Conversion... July 24, 2025 Crypto Market Recap: Bitcoin Breaks US$100,000, Coinbase Makes... May 11, 2025 Crypto Market Recap: New Hampshire Launches First State... May 8, 2025 Finlay Minerals Receives TSX Venture Exchange Approval for... May 3, 2025 Refurbishment of Toll Milling Plant on Track April 30, 2025 Questcorp Mining Continues Exploration in Advance of Drilling... July 7, 2025 A$20 Million Placement to Strategic Partner June 20, 2025